Using lung ultrasound to predict outcomes in newborns with breathing difficulties
The Role of Lung Ultrasonography Score in Predicting Prognosis in Term and Late Preterm Newborns With Postnatal Respiratory Distress
This study is testing if lung ultrasounds can help doctors predict how well newborns with breathing problems will do after birth.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 30 Minutes to 120 Minutes |
| Sex | All |
| Sponsor | Bursa City Hospital Government |
| Locations | 1 site (Bursa) |
| Trial ID | NCT06031324 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the effectiveness of lung ultrasonography scores in predicting the prognosis of term and late preterm newborns experiencing respiratory distress shortly after birth. The study focuses on infants who show symptoms of respiratory distress, aiming to differentiate between various causes such as transient tachypnea and respiratory distress syndrome. By analyzing lung ultrasound results, the researchers hope to provide better prognostic information for affected infants. The study is conducted at Bursa City Hospital, where eligible newborns will be assessed based on specific inclusion and exclusion criteria.
Who should consider this trial
Good fit: Ideal candidates for this study are term and late preterm newborns over 34 weeks gestational age who exhibit symptoms of respiratory distress shortly after birth.
Not a fit: Patients with congenital anomalies, chromosomal anomalies, hydrops fetalis, or congenital heart disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the ability to predict outcomes for newborns with respiratory distress, leading to better management and care.
How similar studies have performed: While the use of lung ultrasonography in newborns is gaining interest, this specific approach to predicting prognosis in respiratory distress is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Having symptoms of respiratory distress that begin soon after birth, * \> 34 gestational age, * \>1900 gr birth weight, * Family consent Exclusion Criteria: * Congenital anomaly * Chromosomal anomaly * Hydrops fetalis * Congenital heart disease
Where this trial is running
Bursa
- Bursa City Hospital — Bursa, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Bayram Ali Dorum
- Email: bayramalidorum@gmail.com
- Phone: +905337078398
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.